Grais Linda — SEC Form 4 filings

SEC reporting owner CIK 1413306. 5 Form 4 filings on record with FilingPulse; latest filed 2026-08-12.

Transaction summary — filings shown

Covers all 5 filings on record, filed 2024-01-31 to 2026-08-12. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
ICON PLC (ICLR)Director14 legs · 841 sh · $138,1693
Corvus Pharmaceuticals, Inc. (CRVS)Director33
ARCA biopharma, Inc. (ABIO)Director11

Form 4 filings — Grais Linda

FiledFormIssuerReported transactionsSource
2026-08-124ICON PLC (ICLR)Option exercise (M): 1,732 · Sale (S): 87 @ $162.72 · Sale (S): 97 @ $163.77 · Sale (S): 590 @ $164.47 · Sale (S): 67 @ $165.51 · Option exercise (M): 1,732 (derivative) @ $0 · +1 moreEDGAR
2026-06-154Corvus Pharmaceuticals, Inc. (CRVS)Grant/award (A): 15,000 (derivative) @ $0EDGAR
2025-06-164Corvus Pharmaceuticals, Inc. (CRVS)Grant/award (A): 15,000 (derivative) @ $0EDGAR
2024-06-174Corvus Pharmaceuticals, Inc. (CRVS)Grant/award (A): 15,000 (derivative) @ $0EDGAR
2024-01-314ARCA biopharma, Inc. (ABIO)Grant/award (A): 6,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1413306 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →